NO993453L - Vannbasert suspensjon til nasal administrering - Google Patents

Vannbasert suspensjon til nasal administrering

Info

Publication number
NO993453L
NO993453L NO993453A NO993453A NO993453L NO 993453 L NO993453 L NO 993453L NO 993453 A NO993453 A NO 993453A NO 993453 A NO993453 A NO 993453A NO 993453 L NO993453 L NO 993453L
Authority
NO
Norway
Prior art keywords
water
nasal administration
based suspension
suspension
nasal
Prior art date
Application number
NO993453A
Other languages
English (en)
Other versions
NO324619B1 (no
NO993453D0 (no
Inventor
Koji Doi
Original Assignee
Bodor Nicholas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor Nicholas filed Critical Bodor Nicholas
Publication of NO993453L publication Critical patent/NO993453L/no
Publication of NO993453D0 publication Critical patent/NO993453D0/no
Publication of NO324619B1 publication Critical patent/NO324619B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO19993453A 1997-01-16 1999-07-13 Vannbasert suspensjon til nasal administrering og anvendelse derav NO324619B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1966497 1997-01-16
PCT/JP1998/000108 WO1998031343A2 (en) 1997-01-16 1998-01-14 Aqueous suspension for nasal administration of loteprednol

Publications (3)

Publication Number Publication Date
NO993453L true NO993453L (no) 1999-07-13
NO993453D0 NO993453D0 (no) 1999-07-13
NO324619B1 NO324619B1 (no) 2007-11-26

Family

ID=12005518

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993453A NO324619B1 (no) 1997-01-16 1999-07-13 Vannbasert suspensjon til nasal administrering og anvendelse derav

Country Status (32)

Country Link
US (1) US6368616B1 (no)
EP (1) EP0973501B1 (no)
KR (1) KR100471708B1 (no)
CN (1) CN1126535C (no)
AR (1) AR011773A1 (no)
AT (1) ATE249205T1 (no)
AU (1) AU730953C (no)
BR (1) BR9806771A (no)
CA (1) CA2278025C (no)
CZ (1) CZ294919B6 (no)
DE (1) DE69818026T2 (no)
DK (1) DK0973501T3 (no)
EA (1) EA001775B1 (no)
ES (1) ES2206880T3 (no)
HU (1) HU226613B1 (no)
ID (1) ID21892A (no)
IL (1) IL130979A0 (no)
LT (1) LT4677B (no)
LV (1) LV12449B (no)
MX (1) MXPA99006628A (no)
NO (1) NO324619B1 (no)
NZ (2) NZ509908A (no)
PL (1) PL190753B1 (no)
PT (1) PT973501E (no)
RS (1) RS49701B (no)
SI (1) SI20057A (no)
SK (1) SK283164B6 (no)
TR (1) TR199901663T2 (no)
TW (1) TW503113B (no)
UA (1) UA52722C2 (no)
WO (1) WO1998031343A2 (no)
ZA (1) ZA98303B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AU762145C (en) 1998-08-26 2005-03-17 Teijin Limited Powdery pernasal compositions
DE19947235A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US6565832B1 (en) * 2000-01-31 2003-05-20 Schering-Plough Healthcare Products, Inc. Spray composition with reduced dripping
IL159415A0 (en) * 2001-06-18 2004-06-01 Noven Pharma Enhanced drug delivery in transdermal systems
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
WO2005000317A1 (en) 2003-06-19 2005-01-06 Bodor Nicholas S Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application
EP1658083B1 (en) * 2003-06-19 2007-08-08 BODOR, Nicholas S. Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
US20050095205A1 (en) * 2003-10-31 2005-05-05 Ramesh Krishnamoorthy Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
ATE441419T1 (de) 2004-03-25 2009-09-15 Bausch & Lomb Verwendung von loteprednoletabonat zur behanldung von trockenen augen
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2007058935A2 (en) * 2005-11-14 2007-05-24 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
AU2012312816A1 (en) 2011-09-22 2014-04-24 Bausch & Lomb Incorporated Ophthalmic gel compositions
HRP20240485T1 (hr) 2017-08-24 2024-07-05 Novo Nordisk A/S Pripravci glp-1 i njihova upotreba
PE20230819A1 (es) 2020-02-18 2023-05-19 Novo Nordisk As Composiciones y usos de glp-1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
EP0709099A3 (en) 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액

Also Published As

Publication number Publication date
DK0973501T3 (da) 2004-01-19
EP0973501B1 (en) 2003-09-10
CN1126535C (zh) 2003-11-05
UA52722C2 (uk) 2003-01-15
AR011773A1 (es) 2000-09-13
SI20057A (sl) 2000-04-30
TR199901663T2 (xx) 1999-09-21
MXPA99006628A (es) 2005-01-10
ZA98303B (en) 1998-07-20
ATE249205T1 (de) 2003-09-15
IL130979A0 (en) 2001-01-28
AU730953B2 (en) 2001-03-22
SK94899A3 (en) 2000-05-16
LT4677B (lt) 2000-07-25
AU5495298A (en) 1998-08-07
PT973501E (pt) 2004-02-27
BR9806771A (pt) 2000-05-16
NZ509908A (en) 2004-12-24
EP0973501A2 (en) 2000-01-26
CZ294919B6 (cs) 2005-04-13
EA199900659A1 (ru) 2000-02-28
NZ336990A (en) 2001-03-30
NO324619B1 (no) 2007-11-26
ES2206880T3 (es) 2004-05-16
LT99100A (en) 2000-02-25
HU226613B1 (en) 2009-04-28
CA2278025A1 (en) 1998-07-23
WO1998031343A3 (en) 1998-09-17
YU36199A (sh) 2002-09-19
EA001775B1 (ru) 2001-08-27
KR100471708B1 (ko) 2005-03-07
HUP0002473A3 (en) 2001-01-29
LV12449B (en) 2000-09-20
NO993453D0 (no) 1999-07-13
CN1250370A (zh) 2000-04-12
TW503113B (en) 2002-09-21
PL334614A1 (en) 2000-03-13
DE69818026D1 (de) 2003-10-16
AU730953C (en) 2002-02-07
DE69818026T2 (de) 2004-07-08
SK283164B6 (sk) 2003-03-04
HK1026138A1 (en) 2000-12-08
LV12449A (lv) 2000-04-20
PL190753B1 (pl) 2006-01-31
CA2278025C (en) 2005-09-06
US6368616B1 (en) 2002-04-09
HUP0002473A2 (hu) 2000-12-28
RS49701B (sr) 2007-12-31
ID21892A (id) 1999-08-05
KR20000070214A (ko) 2000-11-25
WO1998031343A2 (en) 1998-07-23
CZ237499A3 (cs) 2000-01-12

Similar Documents

Publication Publication Date Title
NO993453D0 (no) Vannbasert suspensjon til nasal administrering
DK1035833T3 (da) Sammensætning til nasal indgivelse
DE69838845D1 (de) Zerstäuber
DE59807805D1 (de) Druckzerstäuberdüse
DE69823565D1 (de) Zerstäuber
ID23874A (id) Obat
DK0938345T3 (da) Vandbaseret farmaceutisk sammensætning
FR2771012B1 (fr) Pulverisateur nasal
HUP0100472A3 (en) Novel amines as pharmaceutical agents
NO980546D0 (no) Farmasöytiske midler
DE69816736D1 (de) Nasale Inhaliervorrichtung
GB9815532D0 (en) Pharmaceutical suspension formulation
GB9722600D0 (en) Pharmaceutical compositon
DK0907002T3 (da) Stigrörsunderstötninger
DE69841436D1 (de) Lastaufhängungssystem
DE69815165D1 (de) Aufhängungssystem
ID29294A (id) Komposisi farmasi
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
DE60026647D1 (de) Mehrachsiges Aufhängungssystem
ITBZ980001V0 (it) Guarnitura per mobili
DE69807117D1 (de) Luftdruckstabilisator
NO20000906L (no) Farmasøytisk suspensjon omfattende nevirapin hemihydrat
NO980383D0 (no) Trykk-kompenseringssystem
DE69622377D1 (de) Wasserbasierte korrekturflüssigkeit
ID23531A (id) Komposisi farmasi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees